We are live on
!
Find out more
DIC
Deer IX & Co Portfolio holdings
AUM
$971M
1-Year Est. Return
24.77%
This Fund
S&P 500
This Quarter
Est. Return
+40.33%
1 Year Est. Return
-24.77%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$200M
AUM Growth
–
Cap. Flow
+$207M
Cap. Flow
% of AUM
103.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
nCino
NCNO
|
+$121M |
| 2 |
Kymera Therapeutics
KYMR
|
+$85.6M |
| 3 |
DraftKings
DKNG
|
+$260K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.91% |
| 2 | Healthcare | 48.97% |
| 3 | Consumer Discretionary | 0.13% |
Similar funds
WAM
CCP
AC
KFM
OAM
SIM
LBD
AG
Deer IX & Co's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Deer IX & Co, which disclosed 3 positions worth $200M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is nCino: 1,562,500 shares worth $102M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, followed by Healthcare and Consumer Discretionary.
- Deer IX & Co's largest Q4 2020 buy was nCino: 1,562,500 shares worth $102M.
- Deer IX & Co's ten largest holdings make up 100% of its $200M portfolio in Q4 2020.
- Deer IX & Co disclosed 3 positions in Q4 2020, its first 13F filing on record.
Based on Deer IX & Co's 13F filing for Q4 2020, filed 16 Feb 2021.